Tema Oncology ETF (CANC)
NASDAQ: CANC
· Real-Time Price · USD
29.36
0.66 (2.30%)
At close: Oct 01, 2025, 1:31 PM
2.30% (1D)
| Bid | 29.26 |
| Market Cap | 72.26M |
| AUM | 75.97M |
| NAV | 27.23 |
| EPS (ttm) | 1.06 |
| PE Ratio (ttm) | 27.65 |
| Shares Out | 2.46M |
| Inception Date | Aug 13, 2023 |
| Ask | 29.47 |
| Volume | 6,829 |
| Open | 29.00 |
| Previous Close | 28.70 |
| Day's Range | 29.00 - 29.37 |
| 52-Week Range | 20.10 - 29.37 |
| Holdings | 51 |
| Expense Ratio | 0.75% |
About CANC
The actively managed Tema Oncology ETF seeks to provide long-term growth by investing in companies operating in the oncology industry. Cancer is the second deadliest killer but is on the brink of a revolution in therapeutics and diagnosis.
Asset Class Equity
Ticker Symbol CANC
Inception Date Aug 13, 2023
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 42.57% of assets
| Name | Symbol | Weight |
|---|---|---|
| Revolution Medicines... | RVMD | 6.58% |
| Eli Lilly And Compan... | LLY | 4.97% |
| Genmab A/s | GMAB | 4.95% |
| Bridgebio Pharma, In... | BBIO | 4.53% |
| Roche Holding Ag | RHHBY | 4.28% |
| Merus N.v. | MRUS | 3.97% |
| Arcellx, Inc. | ACLX | 3.72% |
| Nuvalent, Inc. | NUVL | 3.58% |
| Exelixis, Inc. | EXEL | 3.08% |
| Abbvie Inc. | ABBV | 2.91% |
Dividends Dividend Yield 2.78%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 11, 2024 | $0.7283 | Dec 12, 2024 |
| Dec 13, 2023 | $0.1491 | Dec 15, 2023 |
